ImmunoSource: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ImmunoSource
Largest movements
- Cash +€87,617
up €87,617 (+32.8%), from €267,122 to €354,739
mainly Net result for the year (+€92,739) and Current investments (+€79,724)
- Current investments -€79,724
down €79,724 (-7.3%), from €1.1m to €1.0m
- Receivables within one year -€59,344
down €59,344 (-78.9%), from €75,246 to €15,902
- Trade debts -€28,002
down €28,002 (-75.2%), from €37,261 to €9,259
- Reserves -€27,261
down €27,261 (-1.9%), from €1.4m to €1.4m
- Gross operating margin -€40,565
down €40,565 (-31.5%), from €128,859 to €88,294
- Financial income +€27,793
up €27,793 (+51.2%), from €54,307 to €82,100
- Taxes -€18,082
down €18,082 (-44.9%), from €40,297 to €22,216
- Financial charges +€9,363
up €9,363 (+33.6%), from €27,844 to €37,207
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,487,556 | €1,424,796 | -€62,761 | -4.2% |
| Fixed assets | 21/28 | €45,294 | €33,629 | -€11,664 | -25.8% |
| Intangible fixed assets | 21 | €3,660 | €1,739 | -€1,922 | -52.5% |
| Tangible fixed assets | 22/27 | €41,633 | €31,891 | -€9,743 | -23.4% |
| Land and buildings | 22 | €40,412 | €27,046 | -€13,367 | -33.1% |
| Plant, machinery and equipment | 23 | €1,221 | €2,559 | +€1,338 | +109.6% |
| Furniture and vehicles | 24 | - | €2,286 | +€2,286 | |
| Current assets | 29/58 | €1,442,263 | €1,391,166 | -€51,096 | -3.5% |
| Stocks and contracts in progress | 3 | €1,557 | €1,276 | -€281 | -18.0% |
| Stocks | 30/36 | €1,557 | €1,276 | -€281 | -18.0% |
| Amounts receivable within one year | 40/41 | €75,246 | €15,902 | -€59,344 | -78.9% |
| Trade receivables | 40 | €75,246 | €15,902 | -€59,344 | -78.9% |
| Current investments | 50/53 | €1,097,369 | €1,017,645 | -€79,724 | -7.3% |
| Cash at bank and in hand | 54/58 | €267,122 | €354,739 | +€87,617 | +32.8% |
| Deferred charges and accrued income | 490/1 | €968 | €1,603 | +€635 | +65.6% |
| Total equity and liabilities | 10/49 | €1,487,556 | €1,424,796 | -€62,761 | -4.2% |
| Equity | 10/15 | €1,425,818 | €1,398,557 | -€27,261 | -1.9% |
| Contributions | 10/11 | €13,803 | €13,803 | = | 0.0% |
| Reserves | 13 | €1,412,016 | €1,384,755 | -€27,261 | -1.9% |
| Distributable reserves | 133 | €1,412,016 | €1,384,755 | -€27,261 | -1.9% |
| Amounts payable | 17/49 | €61,738 | €26,238 | -€35,500 | -57.5% |
| Amounts payable within one year | 42/48 | €61,699 | €26,194 | -€35,505 | -57.5% |
| Trade debts | 44 | €37,261 | €9,259 | -€28,002 | -75.2% |
| Suppliers | 440/4 | €37,261 | €9,259 | -€28,002 | -75.2% |
| Taxes, remuneration and social security | 45 | €21,370 | €11,662 | -€9,709 | -45.4% |
| Taxes | 450/3 | €21,370 | €11,662 | -€9,709 | -45.4% |
| Other amounts payable | 47/48 | €3,067 | €5,273 | +€2,206 | +71.9% |
| Accrued charges and deferred income | 492/3 | €39 | €44 | +€5 | +13.2% |
| Non-recurring operating income | 76A | - | €9,090 | +€9,090 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €17,111 | €16,120 | -€991 | -5.8% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€179 | - | +€179 | |
| Other operating charges | 640/8 | €2,571 | €2,113 | -€458 | -17.8% |
| Gross operating margin | 9900 | €128,859 | €88,294 | -€40,565 | -31.5% |
| Operating profit (loss) | 9901 | €109,356 | €70,062 | -€39,295 | -35.9% |
| Financial income | 75/76B | €54,307 | €82,100 | +€27,793 | +51.2% |
| Recurring financial income | 75 | €54,307 | €82,100 | +€27,793 | +51.2% |
| Financial charges | 65/66B | €27,844 | €37,207 | +€9,363 | +33.6% |
| Recurring financial charges | 65 | €27,844 | €37,207 | +€9,363 | +33.6% |
| Profit (loss) for the period before taxes | 9903 | €135,819 | €114,954 | -€20,864 | -15.4% |
| Income taxes | 67/77 | €40,297 | €22,216 | -€18,082 | -44.9% |
| Profit (loss) for the period | 9904 | €95,521 | €92,739 | -€2,782 | -2.9% |
| Profit (loss) for the period to be appropriated | 9905 | €95,521 | €92,739 | -€2,782 | -2.9% |
Source: filed annual accounts (NBB), financial years ended 31 July 2024 and 31 July 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.